BMRN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Biomarin Pharmaceutical, Inc.'s quarterly cash and cash equivalents increased from Jun. 2013 ($175.4 Mil) to Sep. 2013 ($181.6 Mil) and increased from Sep. 2013 ($181.6 Mil) to Dec. 2013 ($568.8 Mil).
Biomarin Pharmaceutical, Inc.'s annual cash and cash equivalents increased from Dec. 2011 ($46.3 Mil) to Dec. 2012 ($180.5 Mil) and increased from Dec. 2012 ($180.5 Mil) to Dec. 2013 ($568.8 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Biomarin Pharmaceutical, Inc. Annual Data
Biomarin Pharmaceutical, Inc. Quarterly Data